Consolidated Statement Of Income

STELLA PHARMA CORPORATION - Filing #7248023

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Consolidated statement of income
Statement of income
Net sales
961,058,000 JPY
269,491,000 JPY
Operating expenses
Selling, general and administrative expenses
935,995,000 JPY
977,598,000 JPY
Depreciation
17,025,000 JPY
13,613,000 JPY
Operating expenses
Operating expenses - general
Operating expenses
Gross profit (loss)
845,748,000 JPY
217,298,000 JPY
Operating profit (loss)
-90,246,000 JPY
-760,300,000 JPY
Ordinary profit (loss)
-137,869,000 JPY
-760,208,000 JPY
Operating expenses
Research and development expenses
328,407,000 JPY
393,555,000 JPY
General and administrative expenses
Net sales
Selling, general and administrative expenses
Non-operating income
Interest income
598,000 JPY
11,000 JPY
Interest on securities
688,000 JPY
1,428,000 JPY
Other
106,000 JPY
584,000 JPY
Non-operating income
11,648,000 JPY
4,624,000 JPY
Extraordinary losses
JPY
768,000 JPY
Non-operating expenses
Interest expenses
4,082,000 JPY
2,084,000 JPY
Other
1,953,000 JPY
JPY
Non-operating expenses
59,271,000 JPY
4,533,000 JPY
Share issuance costs
4,310,000 JPY
2,448,000 JPY
Profit (loss) before income taxes
-137,869,000 JPY
-760,976,000 JPY
Gross profit
Income taxes - current
2,941,000 JPY
2,772,000 JPY
Extraordinary losses
Loss on retirement of non-current assets
JPY
768,000 JPY
Income taxes
2,941,000 JPY
2,772,000 JPY
Profit (loss)
-140,811,000 JPY
-140,811,000 JPY
-140,811,000 JPY
-140,811,000 JPY
-763,749,000 JPY
-763,749,000 JPY
-763,749,000 JPY
-763,749,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.